Dabrafenib + Trametinib + PDR001 In Colorectal Cancer

ABSTRACT: This research study is studying a combination of drugs as a possible treatment for metastatic colorectal cancer characterized by BRAF V600E mutation. The names of the study drugs involved in this study are: * Dabrafenib * Trametinib * PDR001

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2283931 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR